Share on LinkedInShare on LinkedIn

ARTICLE · 29 JULY 2020

The USPTO Allows Deadline Extensions Through the CARES Act

Akin
Akin
Contributor
Akin

Akin

Akin is a global law firm with more than 1,100 lawyers and advisors who pride themselves on...

View firm profile
Explore more from Akin

In response to this grant of authority under the CARES ACT, the USPTO published a notice on March 31, 2020, entitled "Notice of Wavier of Patent-Related Timing Deadlines under the [CARES] Act"...

United StatesCoronavirus (COVID-19)

Keep up to date with Akin Gump Strauss Hauer & Feld's COVID-19 Resource Centre

Key Points:

  • The CARES Act grants the Director of the USPTO temporary authority to "toll, waive, adjust, or modify" statutory deadlines under the Title 35 of the United States Code governing patent law.
  • In a Notice published on March 31, 2020, the USPTO issued guidelines to allow 30-day extensions of certain filings and pleadings for those affected by the COVID-19 national emergency.
  • In addition, the USPTO provides for the extension of certain deadlines in inter partes reviews and other proceedings at the PTAB.

In response to this grant of authority under the CARES ACT, the USPTO published a notice on March 31, 2020, entitled "Notice of Wavier of Patent-Related Timing Deadlines under the [CARES] Act" (link here) ("Notice"). In that Notice, the Director of the USPTO determined that the national emergency relating to the COVID-19 outbreak "has prejudiced the rights of

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from